Article info
PDFBasic science
Experimental research
PGC-1α Gly482Ser polymorphism increases the susceptibility to NAFLD in type 2 diabetic patients
Citation
PGC-1α Gly482Ser polymorphism increases the susceptibility to NAFLD in type 2 diabetic patients
Publication history
- First published October 12, 2011.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions